DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
-15.04%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
(-6.6%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
16.05%
Top 10 Holdings %
Top 10 Hldgs %
49.78%
Holding
57
New
6
Increased
22
Reduced
11
Closed
6
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$54.2M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$42.9M |
| 3 |
Nuvation Bio
NUVB
|
$33.4M |
| 4 |
Nurix Therapeutics
NRIX
|
$30.9M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$24.4M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$75.7M |
| 2 |
Keros Therapeutics
KROS
|
$17.7M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$16.3M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$14.1M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$9.25M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crinetics Pharmaceuticals
CRNX
$2.92B
| $19.6M | 1.29% | 1,053,000 -488,715 | -32% | -$9.11M |
|
27
KalVista Pharmaceuticals
KALV
$678M
| $17.9M | 1.18% | 1,824,000 +94,243 | +5% | +$927K |
|
|
DICE
28
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $16.2M | 1.06% | 1,042,900 -207,100 | -17% | -$3.21M |
|
|
INZY
29
DELISTED
Inozyme Pharma
INZY
| $15.5M | 1.02% | +3,250,000 | New | +$15.5M |
|
30
Schrodinger
SDGR
$1.44B
| $14.8M | 0.98% | +562,000 | New | +$14.8M |
|
31
Acumen Pharmaceuticals
ABOS
$82.4M
| $14.6M | 0.96% | 3,100,000 +500,902 | +19% | +$2.35M |
|
32
AnaptysBio
ANAB
$569M
| $13.7M | 0.9% | 672,569 +113,787 | +20% | +$2.31M |
|
33
Viridian Therapeutics
VRDN
$1.5B
| $13.5M | 0.89% | 1,170,290 | – | – |
|
34
Adicet Bio
ACET
$59.9M
| $13M | 0.86% | +892,028 | New | +$13M |
|
|
JNCE
35
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $12.9M | 0.85% | 4,259,653 | – | – |
|
|
SLN
36
Silence Therapeutics
SLN
$227M
| $11.3M | 0.74% | 951,580 | – | – |
|
37
Relmada Therapeutics
RLMD
$37.2M
| $9.5M | 0.62% | 500,000 +397,883 | +390% | +$7.56M |
|
|
HOOK
38
DELISTED
HOOKIPA Pharma
HOOK
| $8.21M | 0.54% | 5,035,998 | – | – |
|
39
Century Therapeutics
IPSC
$42.5M
| $7.77M | 0.51% | 924,641 -1,828 | -0.2% | -$15.4K |
|
40
Dianthus Therapeutics
DNTH
$759M
| $6.43M | 0.42% | 5,359,000 | – | – |
|
41
Assembly Biosciences
ASMB
$190M
| $6.3M | 0.41% | 3,000,000 | – | – |
|
|
SAGE
42
DELISTED
Sage Therapeutics
SAGE
| $5.55M | 0.36% | 171,800 -503,200 | -75% | -$16.3M |
|
43
Passage Bio
PASG
$22.7M
| $5.48M | 0.36% | 2,320,000 -1,055,000 | -31% | -$2.49M |
|
44
GH Research
GHRS
$837M
| $4.98M | 0.33% | 499,400 | – | – |
|
45
Fulcrum Therapeutics
FULC
$351M
| $4.9M | 0.32% | 1,000,000 +350,000 | +54% | +$1.72M |
|
|
GRTS
46
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $4.16M | 0.27% | 1,720,000 -1,265,729 | -42% | -$3.06M |
|
47
Tenaya Therapeutics
TNYA
$184M
| $2.72M | 0.18% | 483,836 -63,087 | -12% | -$355K |
|
|
ATYR
48
aTyr Pharma
ATYR
$527M
| $823K | 0.05% | 290,844 -737,671 | -72% | -$2.09M |
|
|
VIGL
49
DELISTED
Vigil Neuroscience
VIGL
| $796K | 0.05% | 308,393 -80,748 | -21% | -$208K |
|
|
50
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – | -463,663 | Closed | -$75.7M |
|